Science & Enterprise subscription

Follow us on Twitter

  • Results from a large-scale clinical trial show almost the same health outcomes for patients prescribed high or low… https://t.co/cAg7Ygkv3I
    about 19 hours ago
  • New post on Science and Enterprise: Trial Shows Same High/Low Dose Aspirin Outcomes https://t.co/N8mjm3cWX8 #Science #Business
    about 19 hours ago
  • Venture funding for start-ups providing artificial intelligence services in health care climbed to a record high vo… https://t.co/FHzRPWsgKR
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Health Care A.I. Funds Jump in Q1 https://t.co/4L1DrqPRFT #Science #Business
    about 3 days ago
  • This New York Times essay got here just in time ... Your Car, Toaster, Even Washing Machine, Can’t Work Without The… https://t.co/cuRLpV3PIT
    about 3 days ago

Please share Science & Enterprise

Moderna Supplying 500M Vaccine Doses to Covax

Vaccine delivery to Philippines

Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries. . . . → Read More: Moderna Supplying 500M Vaccine Doses to Covax

Infographic – Covid-19 Vaccine Acceptance Gains Worldwide

Chart: Willingness to get vaccine

Polling from across the world indicates that since the start of 2021, larger numbers of residents are vaccinated or plan to get vaccinated against the virus. . . . → Read More: Infographic – Covid-19 Vaccine Acceptance Gains Worldwide

Trial Shows Malaria Vaccine Protects Young Children

Malaria clinic in Cameroon

Results from a clinical trial in Burkina Faso show a high efficacy rate for a candidate vaccine to protect young children against malaria infections. . . . → Read More: Trial Shows Malaria Vaccine Protects Young Children

Trials Adding Covid-19 Hospital, Out-Patient Therapies

SARS-CoV-2 particle

National Institutes of Health is adding a new treatment to a clinical trial for Covid-19 patients hospitalized with severe respiratory failure. . . . → Read More: Trials Adding Covid-19 Hospital, Out-Patient Therapies

Microbiome Health Company Raises $40M in Early Funds

Gut microbes illustration

A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round. . . . → Read More: Microbiome Health Company Raises $40M in Early Funds

Start-Up Designing Synthetic DNA for Gene Therapies

DNA puzzle

A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses. . . . → Read More: Start-Up Designing Synthetic DNA for Gene Therapies

Challenge Trial Testing Covid-19 Reinfection

SARS-Cov-2 virus

A clinical trial is underway testing immune responses from new Covid-19 infections in volunteers previously infected with the virus. . . . → Read More: Challenge Trial Testing Covid-19 Reinfection

Infographic – Israel Halts Covid-19 Spread with Vaccines

Chart: Covid-19 cases in Israel

Israel is emerging as the world’s leader in vaccinating its population, and seeing results in declines of new Covid-19 cases. . . . → Read More: Infographic – Israel Halts Covid-19 Spread with Vaccines

Lilly Asks FDA to Revoke Covid-19 Therapy Clearance

SARS-CoV-2 and cell

Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections. . . . → Read More: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance

Novavax Joins Alternative Second Shot Vaccine Trial

Syringes

Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations. . . . → Read More: Novavax Joins Alternative Second Shot Vaccine Trial